Determination of Levodopa and Benserazide Hydrochloride in Pharmaceutical Formulations by CZE with Amperometric Detection
- 28 February 2005
- journal article
- Published by Springer Nature in Chromatographia
- Vol. 61 (5-6), 265-270
- https://doi.org/10.1365/s10337-005-0515-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Determination of active ingredients in Huangdan Yinchen Keli by CZE with amperometric detectionJournal of Pharmaceutical and Biomedical Analysis, 2004
- DETERMINATION OF BINARY MIXTURES OF LEVODOPA AND BENSERAZIDE IN PHARMACEUTICALS BY RATIO-SPECTRA DERIVATIVE SPECTROPHOTOMETRYAnalytical Letters, 2002
- Separation and determination of β-agonists in serum by capillary zone electrophoresis with amperometric detectionAnalytica Chimica Acta, 2001
- Separation and determination of levodopa and carbidopa in composite tablets by capillary zone electrophoresis with amperometric detectionAnalytica Chimica Acta, 2001
- Quality control of benserazide-levodopa and carbidopa-levodopa tablets by capillary zone electrophoresisElectrophoresis, 2000
- End-column amperometric detection of aesculin and aesculetin by capillary electrophoresisAnalytica Chimica Acta, 1999
- Determination of adenosine phosphate by co-electroosmotic capillary electrophoresis with amperometric detectionAnalytica Chimica Acta, 1999
- Derivative Spectrophotometric Determination of Levodopa and Benserazide HydrochlorideAnalytical Letters, 1990
- Sepectrometric Determination of Madopar CapsulesAnalytical Letters, 1990
- L-Dopa and ParkinsonismNature, 1970